Shell Asset Management’s Avanos Medical AVNS Stock Holding History

Shell Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-24,489	Closed	-$1.1M	–	1200
2018 Q4	$1.1M	Sell	24,489 -2,100	-8%	-$110K	0.03%	479
2018 Q3	$1.82M	Hold	26,589	–	–	0.04%	414
2018 Q2	$1.52M	Sell	26,589 -1,415	-5%	-$74.8K	0.03%	481
2018 Q1	$1.29M	Hold	28,004	–	–	0.03%	555
2017 Q4	$1.29M	Hold	28,004	–	–	0.03%	539
2017 Q3	$1.26M	Sell	28,004 -700	-2%	-$29.9K	0.03%	507
2017 Q2	$1.13M	Hold	28,704	–	–	0.02%	576
2017 Q1	$1.09M	Sell	28,704 -2,009	-7%	-$78.3K	0.02%	583
2016 Q4	$1.14M	Sell	30,713 -268	-0.9%	-$9.58K	0.03%	593
2016 Q3	$1.07M	Buy	+30,981	New	+$1.09M	0.02%	627

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Shell Asset Management's AVNS Position: Q1 2019 in Review

Shell Asset Management sold out of Avanos Medical (AVNS) in Q1 2019, closing a stake of 24,489 shares — an estimated $1.1M sold.

Shell Asset Management first reported a position in AVNS in Q3 2016 and held it in 10 quarters. The position peaked at $1.82M in Q3 2018. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2019.

Shell Asset Management reported no remaining Avanos Medical position as of Q1 2019 after selling out during the quarter.
Shell Asset Management sold 24,489 Avanos Medical shares in Q1 2019, an estimated $1.1M.
Shell Asset Management first reported a position in Avanos Medical in Q3 2016 and held it in 10 quarters.
Shell Asset Management's Avanos Medical position peaked at $1.82M in Q3 2018.
338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2019.

Based on Shell Asset Management's 13F filing for Q1 2019, filed 9 May 2019.